Pharma News

‘Pharma burnout’: Industry reputation slumps in first half of 2022, study finds

Industry Specific Insights31 Oct, 2022

"The biopharma industry reputation is sliding again — and alarmingly fast. The pharmaceuticals, biotechnology and life sciences category fell almost 3 points (2.9) between the first and second quarter of 2022, according to corporate reputation monitor RepTrak."

Read the full article here.

Related Blog Post stories